High Blood Pressure
When the heart beats, it pumps blood into the arteries, building up pressure – systolic blood pressure – on the walls of the blood vessels.
https://pharma.bayer.com/high-blood-pressure
1 - 10 of about 173 Documents
Chronic Kidney Disease
Chronic kidney disease (CKD) is one of the most frequent complications arising from diabetes and is an independent risk factor of cardiovascular disease.
https://pharma.bayer.com/chronic-kidney-disease
Stroke & Atrial Fibrillation
Stroke is the second most common cause of death worldwide, responsible for 6.7 million deaths each year. Of those who survive a stroke, 5 million are left disabled every year.
https://pharma.bayer.com/stroke-atrial-fibrillation
Pulmonary Hypertension
Pulmonary hypertension is a disorder in which the blood vessels in the lungs become more and more narrow. As a result, less blood reaches the air sacs (alveoli) in the lungs, hampering oxygen uptake.
https://pharma.bayer.com/pulmonary-hypertension
Exclusive Treatment Approved for Rare TRK Fusion Cancers
Approval of first tumor-agnostic therapy in Europe marks meaningful advancement in cancer care.
https://pharma.bayer.com/approval-first-tumor-agnostic-therapy-europe
Survival Signaling
The 'survival signaling' research field is concerned with blocking the survival signals of the cancer cells.
https://pharma.bayer.com/survival-signaling
New Treatment Approval for nmCRPC Prostate Cancer
The U.S. Food and Drug Administration (FDA) has approved a new, unique androgen receptor inhibitor (ARi) that delays metastases and extends survival.
https://pharma.bayer.com/new-treatment-men-non-metastatic-castration-resistant-prostate-cancer-approved-us-fda
Access Accelerated: Bayer Kicks Off Project in Ghana
The project “Center of Excellence” aims to train healthcare professionals and strengthen the infrastructure of the public health sector in Ghana.
https://pharma.bayer.com/access-accelerated-bayer-kicks-project-ghana
Advancing Innovation May Advance Latin America's Economies, Part 1/3
Innovations in pharma need framework conditions that adapt to the constantly changing environment and the ever new challenges in terms of innovation and market access.
https://pharma.bayer.com/advancing-innovation-may-advance-latin-americas-economies-part-13
Advancing Innovation May Advance Latin America’s Economies, Part 2/3
Local parameters shape the framework conditions for innovations in pharma in Latin America.
https://pharma.bayer.com/advancing-innovation-may-advance-latin-americas-economies-part-23